What's happening with UnitedHealth (UNH)? Shares fell 15% in two days after Medicare's new $90 billion audit rule

UnitedHealth dropped 10.2% to $349.91 on November 18 after a 5.4% fall the day before, and Humana lost 13% to $385.78. The trigger is CMS's proposed CRUSH rule, which would let Medicare claw back overpayments to private insurers going back to 2018.
America's biggest health insurers just had their worst two days in months. The trigger was a proposal from Washington, not an earnings report: the government wants to audit Medicare Advantage plans much harder and recover money going back years.
What happened
- Monday, November 16. The Centers for Medicare & Medicaid Services (CMS) published a proposed anti-fraud rule called CRUSH ("Comprehensive Regulations to Uncover Suspicious Healthcare"). CMS estimates it saves about $90 billion from 2027 to 2036.
- Tuesday, November 17. UnitedHealth fell 5.4% to $389.68 while the S&P 500 lost 1%. Every other large managed-care stock fell too, with a median drop of 3.9%. Humana lost 3.9%.
- Wednesday, November 18 — the big drop. UNH fell another 10.2% to $349.91, roughly 15% below Monday's close. Humana fell 13% to $385.78, Elevance about 7.6% and CVS Health 5.2% to $81.35. The S&P 500 slipped only about 0.2%.
Why it moved
The fall is about one specific part of the rule. Medicare pays private insurers more for sicker patients, and CMS checks this with RADV audits: it pulls a sample of medical records and checks whether the diagnoses are backed up. Under CRUSH, an error rate found in the sample would be extrapolated to the whole plan contract, starting from payment year 2018. CMS puts possible recoveries at about $9 billion per payment year. Oppenheimer notes that almost all of the projected savings come from Medicare Advantage insurers.
UnitedHealth and Humana are the two biggest Medicare Advantage players, so they took the hardest hit. Cigna fell far less (about 3%) because it sold its Medicare Advantage business in 2025.
There are also reasons the damage may be smaller than feared. It is only a proposal: public comments are open until January 19, 2027. Analysts expect lawsuits, since a federal court threw out the previous RADV rule in September 2025. Mizuho says the real cost is still uncertain. Raymond James adds that Senator Bernie Sanders' new Medicare for All push weighed on the stocks too, but in its view investors are overrating that risk. UnitedHealth made no comment. Humana declined to comment. CVS said it was confident in its risk-adjustment practices.
The numbers right now
UNH trades at $330.48 and Humana at $380.00. UnitedHealth is roughly 40–45% below its November 2024 peak, and Humana is about 30% below its 2022 high. Before this week, UNH was up about 8% for the year. See how far other assets are from their highs on our from-ATH page.
What it means if you buy regularly
Drops caused by regulation can last longer than ordinary market dips, because the outcome depends on courts and rule-making, not on next quarter's profit. Someone who put $10 a day into UnitedHealth over the last five years has invested $18,260 and now holds $14,448 (−20.9%). The same plan in Humana is worth $20,661 (+13.1%), and in the S&P 500 (SPY) $26,246 (+43.7%). That is history, not a forecast. Compare other assets in the DCA calculator.
Sources
- JournalArta — UnitedHealth shares fall 10.2% amid Medicare audit proposal
- Beinsure — Healthcare stocks fall as new Medicare rules trigger a sell-off
- Trefis — Why is UnitedHealth stock falling? (Nov 17)
- Trefis — S&P 500 movers, November 18
- Rise Health — What the CMS CRUSH proposed rule means for Medicare Advantage
Not investment advice.
👀 Track it on WhatIfStack
Add these assets to your free watchlist or portfolio — live prices, profit and news in one place, no sign-up.
Once a week: what happened to crypto, stocks and gold, the best and worst assets, and our top articles. No spam.
Only the weekly report. Unsubscribe in one click from any e-mail.